Editorial: Enhancing innate immunity in combination therapy for solid tumors.
作者信息
Pejoski David
机构信息
Adoram Therapeutics, Geneva, Switzerland.
School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.
出版信息
Front Immunol. 2025 Jan 3;15:1539027. doi: 10.3389/fimmu.2024.1539027. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Enhancing innate immunity in combination therapy for solid tumors.社论：在实体瘤联合治疗中增强固有免疫
Front Immunol. 2025 Jan 3;15:1539027. doi: 10.3389/fimmu.2024.1539027. eCollection 2024.
2
Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer.联合靶向固有免疫和适应性免疫的疗法改善了卵巢癌临床前模型中的生存。
J Immunother Cancer. 2019 Jul 30;7(1):199. doi: 10.1186/s40425-019-0654-5.
3
Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy.利用生物材料激发固有免疫用于癌症免疫治疗。
Adv Mater. 2021 Jul;33(27):e2007576. doi: 10.1002/adma.202007576. Epub 2021 May 29.
4
Immuno-oncology-101: overview of major concepts and translational perspectives.免疫肿瘤学 101：主要概念和转化视角概述。
Semin Cancer Biol. 2018 Oct;52(Pt 2):1-11. doi: 10.1016/j.semcancer.2018.02.005. Epub 2018 Feb 8.
5
Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.核酸传感机制：针对癌症治疗的先天免疫系统
Recent Pat Anticancer Drug Discov. 2018;13(1):2-17. doi: 10.2174/1574892812666171030163804.
6
Small molecule innate immune modulators in cancer therapy.小分子天然免疫调节剂在癌症治疗中的应用。
Front Immunol. 2024 Sep 10;15:1395655. doi: 10.3389/fimmu.2024.1395655. eCollection 2024.
7
Myelopoiesis during Solid Cancers and Strategies for Immunotherapy.实体瘤中的骨髓造血和免疫治疗策略
Cells. 2021 Apr 21;10(5):968. doi: 10.3390/cells10050968.
8
Immunogenic cell death in cancer immunotherapy.肿瘤免疫治疗中的免疫原性细胞死亡。
BMB Rep. 2023 May;56(5):275-286. doi: 10.5483/BMBRep.2023-0024.
9
Purinergic targeting enhances immunotherapy of CD73 solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells.嘌呤能靶向增强猪源 Bac 工程嵌合抗原受体自然杀伤细胞治疗 CD73 实体瘤的免疫疗法。
J Immunother Cancer. 2018 Dec 4;6(1):136. doi: 10.1186/s40425-018-0441-8.
10
Personalized Immuno-Oncology.个性化免疫肿瘤学。
Med Princ Pract. 2021;30(1):1-16. doi: 10.1159/000511107. Epub 2020 Aug 25.
本文引用的文献
1
Rational combination of cancer therapies with PD1 axis blockade.癌症治疗与PD1轴阻断的合理联合
Nat Rev Cancer. 2024 Jul 30. doi: 10.1038/s41568-024-00727-1.
2
Editorial: New insights into innate immune cell-based immunotherapies in cancer.社论：癌症中基于先天免疫细胞的免疫疗法的新见解
Front Immunol. 2024 Apr 9;15:1401665. doi: 10.3389/fimmu.2024.1401665. eCollection 2024.
3
Harnessing innate immune pathways for therapeutic advancement in cancer.利用先天免疫途径推进癌症治疗的进展。
Signal Transduct Target Ther. 2024 Mar 25;9(1):68. doi: 10.1038/s41392-024-01765-9.
4
Breakthrough of solid tumor treatment: CAR-NK immunotherapy.实体瘤治疗的突破：CAR-NK免疫疗法。
Cell Death Discov. 2024 Jan 20;10(1):40. doi: 10.1038/s41420-024-01815-9.
5
Modulation of tumor microenvironment by targeting histone acetylation in bladder cancer.通过靶向组蛋白乙酰化调控膀胱癌肿瘤微环境
Cell Death Discov. 2024 Jan 4;10(1):1. doi: 10.1038/s41420-023-01786-3.
6
Multifunctional nanoparticle-mediated combining therapy for human diseases.多功能纳米颗粒介导的人类疾病联合治疗。
Signal Transduct Target Ther. 2024 Jan 1;9(1):1. doi: 10.1038/s41392-023-01668-1.
7
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations.免疫疗法联合治疗方法：机制、生物标志物和临床观察。
Nat Rev Immunol. 2024 Jun;24(6):399-416. doi: 10.1038/s41577-023-00973-8. Epub 2023 Dec 6.
8
Exploiting innate immunity for cancer immunotherapy.利用先天免疫进行癌症免疫治疗。
Mol Cancer. 2023 Nov 27;22(1):187. doi: 10.1186/s12943-023-01885-w.
9
Advances in early detection methods for solid tumors.实体瘤早期检测方法的进展
Front Genet. 2023 Feb 24;14:1091223. doi: 10.3389/fgene.2023.1091223. eCollection 2023.
10
Toll-like receptor-targeted anti-tumor therapies: Advances and challenges. Toll 样受体靶向抗肿瘤治疗：进展与挑战。
Front Immunol. 2022 Nov 21;13:1049340. doi: 10.3389/fimmu.2022.1049340. eCollection 2022.
Zotero 插件